SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : TATRADER GIZZARD STUDY--Stocks 12.00 or Less..... -- Ignore unavailable to you. Want to Upgrade?


To: TATRADER who wrote (11374)9/29/1999 4:40:00 PM
From: YxY  Read Replies (1) | Respond to of 59879
 
THDO, I mentioned this one a few weeks ago, nice to see it was on your watch list too.

ASL besides TA seems to have very good earning growth prospects and low PE compared to its peers



To: TATRADER who wrote (11374)9/29/1999 5:44:00 PM
From: WHL  Respond to of 59879
 
CLST reported $.25 for quarter after the close (trading at $7.375). (Its market cap is $400 million- which is equivalent to 2 months revenues.) Look for a wild day tomorrow for this stock with 25% growth rates and a P/E of 7, because this company also indicated:

According to First Call at the time of the publication of this release, the range of the analysts' estimates for the fourth quarter was $0.33 to $0.37 in net income per diluted share, apart from non-recurring gains or charges. These estimates were based on revenue estimates ranging from approximately $725 million to $850 million. The Company believes its fourth quarter performance will be within these ranges, barring negative factors beyond its control.

Consequently, CellStar currently expects to report record revenues and earnings per share for both the quarter and year ended November 30, 1999; and expects to carry strong growth and earnings momentum into fiscal 2000, when the Company also expects to report another record year.